2023
Specific targeting of inflammatory osteoclastogenesis by the probiotic yeast S. boulardii CNCM I-745 reduces bone loss in osteoporosis.
Madel MB, Halper J, Ibáñez L, Claire L, Rouleau M, Boutin A, Mahler A, Pontier-Bres R, Ciucci T, Topi M, Hue C, Amiaud J, Iborra S, Sancho D, Heymann D, Garchon HJ, Czerucka D, Apparailly F, Duroux-Richard I, Wakkach A, Blin-Wakkach C.
Journal: eLife
Année: Février 2023
RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass
Bonnet N, Bourgoin L, Biver E, Douni E, Ferrari S
Journal: The Journal of Clinical Investigation
Année: feb 2023
Volume: 133
Pages: 169-317
Preserving bone in cancers of the elderly: a necessity
Bertrand N, Bridoux M, Gaxatte C, Rached HA, Turpin A, Letarouilly JG, Vieillard MH.
Journal: Joint Bone Spine
Volume: 90, Issue 4
Année: Juillet 2023
Pages: 105549
Multi-frequency shear modulus measurements discriminate tumorous from healthy tissues
Nicolle S, Palierne JF, Mitton D, Follet H, Confavreux CB
Journal: Journal of the Mechanical Behavior of Biomedical Materials
Année: apr 2023
Volume: 140
Pages: 105-721
Advances in PET and MRI imaging of tumor hypoxia
Gouel P, Decazes P, Vera P, Gardin I, Thureau S, Bohn P.
Journal: Frontiers in Medicine
Volume: 10
Année: Février 2023
Could conventionally fractionated radiation therapy coupled with stereotactic body radiation therapy improve local control in bone oligometastases?
Py JF, Salleron J, Vogin G, Courrech F, Teixeira P, Colnat-Coulbois S, Baumard F, Thureau S, Supiot S, Peiffert D, Oldrini G, Faivre JC.
Journal: Cancer Radiother.
Année: Feb 2023
Volume: 27(1):1-10
Advances in osteosarcoma
Panez-Toro I, Muñoz-García J, Vargas-Franco JW, Renodon-Cornière A, Heymann MF, Lézot F, Heymann D.
Curr Osteoporosis Rep,
in press
2022
Osteosarcoma
Beird HC, Bielack SS, Flanagan AM, Gill J, Heymann D, Janeway KA, Livingston JA, Roberts RD, Strauss SJ, Gorlick R.
Journal: Nature Revieuws Disease Primers
Article number: 77
Année: Décembre 2022
Impact of Bone Metastases on Patients with Renal Cell Carcinoma or Melanoma Treated with Combotherapy Ipilimumab Plus Nivolumab.
Pham F, Belkaid S, Maillet D, Confavreux CB, Dalle S, Péron J. Biomedicines
Journal: Biomedicines
Volume: 10, Issue 11
Année: Octobre 2022
Pages: 2758
Lipopolysaccharide-binding protein expression is associated to the metastatic status of osteosarcoma patients
Heymann CJF, Bobin-Dubigeon C, Muñoz-Garcia J, Cochonneau D, Ollivier E, Heymann MF, Heymann D
Journal: Journal of Bone Oncology
Volume: 36
Année: Octobre 2022
Pages: 100451